Executives
-
Johnson Rady AExecutive Vice President -
Bourla AlbertChairman & CEO
-
Fonseca LidiaExecutive Vice President
-
Denton David MChief Financial Officer & EVP
-
Mcdermott MichaelExecutive Vice President
-
Dolsten MikaelPresident R&D
-
Susman SallyExecutive Vice President
-
Malik AamirExecutive Vice President
-
Sahni PayalExecutive Vice President
-
Lankler Douglas MExecutive Vice President
-
Damico Jennifer B.SVP & Controller
-
Baum AndrewExecutive Vice President
-
Boshoff ChristoffelExecutive Vice President
-
De Germay AlexandreExecutive Vice President
?
Boshoff Christoffel
Executive Vice President
Pfizer Inc.
US, New York [HQ]
CIK
1988687
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
1,487,030,000
Price per Share :
$26.49
Equivalence :
$39,391,424,700.00
Transaction History
-
M1,487,030,000 Shares After TransactionValue : $40,655,400,200.00$2,666,196,800.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#3 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#4 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#5 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#6 Price is the closing price of Pfizer common stock on February 23, 2024.
-
F1,482,450,000 Shares After TransactionValue : $41,152,812,000.00$127,140,800.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#3 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#4 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#5 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#6 Price is the closing price of Pfizer common stock on February 23, 2024.
-
F1,475,700,000 Shares After TransactionValue : $40,965,432,000.00$187,380,000.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#3 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#4 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#5 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#6 Price is the closing price of Pfizer common stock on February 23, 2024.
-
F1,396,890,000 Shares After TransactionValue : $38,232,879,300.00$2,157,029,700.00Transaction Date : 02/23/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#3 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#4 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#5 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#6 Price is the closing price of Pfizer common stock on February 23, 2024.
-
F1,393,890,000 Shares After TransactionValue : $38,694,386,400.00$83,280,000.00Transaction Date : 02/24/24
-
Footnotes
-
-
Footnotes:#1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).#2 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).#3 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.#4 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).#5 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.#6 Price is the closing price of Pfizer common stock on February 23, 2024.